XOMA Corp. (XOMA +1.8%) trades up after saying it's selected active non-infectious anterior...

|About: XOMA Corporation (XOMA)|By:, SA News Editor

XOMA Corp. (XOMA +1.8%) trades up after saying it's selected active non-infectious anterior scleritis, the inflammation of the fibrous white membrane surrounding the eyeball excluding the cornea, as the third indication in it's proof-of-concept program for gevokizumab. The company will work with the National Eye Institute on designing the study protocol.